Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Shogaol (specifically [6]-shogaol) is a pungent, bioactive phenolic compound present in ginger, formed primarily when ginger is dried or cooked. It is structurally related to gingerol but has higher potency for several biological activities, including anti-inflammatory, antioxidant, and cytotoxic effects against cancer cell lines. Shogaol exerts its effects through modulation of signaling pathways such as MAPK and antioxidant response, but it is not itself a molecular target such as a receptor or enzyme. Instead, it is classified as a natural product or phytochemical and is not a canonical druggable target for therapeutic intervention[4][1][2][7].
Induces phosphorylation of MAPKs (ERK, JNK, p38); Upregulates Nrf2/HO-1 pathway (antioxidant response); Inhibits reactive oxygen species generation (in vitro in neutrophils)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 6-Shogaol.